Background Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for
patients with severe aortic stenosis who are not suitable candidates for surgery. The …

Background Many patients with severe aortic stenosis and coexisting conditions are not
candidates for surgical replacement of the aortic valve. Recently, transcatheter aortic-valve …

Background—The long-term outcomes of transcatheter aortic valve replacement (TAVR) in
inoperable patients with severe aortic stenosis remain unknown. Methods and Results—In …

Background We compared transcatheter aortic-valve replacement (TAVR), using a self-
expanding transcatheter aortic-valve bioprosthesis, with surgical aortic-valve replacement in …

Background A previous analysis in this trial showed that among patients with severe,
symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end …

Background Based on the early results of the Placement of Aortic Transcatheter Valves
(PARTNER) trial, transcatheter aortic valve replacement (TAVR) is an accepted treatment for …

Background—The Placement of Aortic Transcatheter Valves (PARTNER) trial demonstrated
similar survival after transcatheter and surgical aortic valve replacement (TAVR and SAVR …

Background There are scant data on long-term clinical outcomes and bioprosthetic-valve
function after transcatheter aortic-valve replacement (TAVR) as compared with surgical …

Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that
among high-risk patients with aortic stenosis, the 1-year survival rates are similar with …

Transcatheter aortic valve implantation (TAVI) with the Cribier-Edwards prosthesis may
provide an alternative to conventional aortic valve replacement in high-risk patients with …